Madison Investment Advisors’s Elevance Health ELV Stock Holding History

Madison Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$22.9M	Buy	+62,081	New	+$26M	0.26%	87

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Madison Investment Advisors's ELV Position: Q4 2024 in Review

Madison Investment Advisors opened a new position in Elevance Health (ELV) in Q4 2024: 62,081 shares worth $22.9M. The stake represents 0.26% of the portfolio and ranks #87 among its holdings.

1,605 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Madison Investment Advisors held 62,081 shares of Elevance Health worth $22.9M as of Q4 2024.
Elevance Health was a new Madison Investment Advisors position in Q4 2024.
Elevance Health made up 0.26% of Madison Investment Advisors's portfolio in Q4 2024, its #87 holding.
1,605 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Madison Investment Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.